Variable | Totala | Randomization group Intervention, N = 178; control, N = 192 | p | |
---|---|---|---|---|
N (column %) | n (row %) | n (row %) | ||
Age in years; median (IQR) | 39 (30–49) | 38 (29–48) | 40 (32–49) | 0.057 |
Age group | 370 | 178 | 192 | 0.725 |
 Adolescent (< 20 yrs) | 10 (2.7) | 6 (60.0) | 4 (40.0) |  |
 Adult (20–50 yrs) | 289 (78.1) | 139 (48.1) | 150 (51.9) |  |
 Elderly adult (> 50 yrs) | 71 (19.2) | 33 (46.5) | 38 (53.5) |  |
Sex | 370 | 178 | 192 | 0.601 |
 Female | 244 (65.9) | 115 (47.1) | 129 (52.9) |  |
 Male | 126 (34.1) | 63 (50.0) | 63 (50.0) |  |
Marital status | 369 | 178 | 191 | 0.122 |
 Single | 135 (36.6) | 76 (56.3) | 59 (43.7) |  |
 Couple | 187 (50.7) | 83 (44.4) | 104 (55.6) |  |
 Divorced/separated | 13 (3.5) | 5 (38.5) | 8 (61.5) |  |
 Widow(er) | 34 (9.2) | 14 (41.2) | 20 (58.8) |  |
Time to reach treatment center | 369 | 178 | 191 | < 0.001 |
 Less than 30 min | 155 (42.0) | 131 (84.5) | 24 (15.5) |  |
 30 min to 2 h | 177 (48.0) | 36 (20.3) | 141 (79.7) |  |
 More than 2 h | 37 (10.0) | 11 (29.7) | 26 (70.3) |  |
HIV status disclosure | 369 | 177 | 192 | 0.588 |
 No, to none of them | 85 (23.0) | 42 (49.4) | 43 (50.6) |  |
 Yes, to some of them | 196 (53.1) | 97 (49.5) | 99 (50.5) |  |
 Yes, to all of them | 88 (23.9) | 38 (43.2) | 50 (56.8) |  |
WHO disease stage | 359 | 174 | 185 | 0.299 |
 Stage I and II | 318 (88.6) | 151 (47.5) | 167 (52.5) |  |
 Stage III and IV | 41 (11.4) | 23 (56.1) | 18 (43.9) |  |
Drug at the start | 352 | 169 | 183 | 0.161 |
 Efavirenz-based regimen | 303 (86.1) | 144 (47.5) | 159 (52.5) |  |
 Nevirapine-based regimen | 25 (7.1) | 16 (64.0) | 9 (36.0) |  |
 Dolutegravir-based regimen | 24 (6.8) | 9 (37.5) | 15 (62.5) |  |
Level of knowledge on health status | 367 | 177 | 190 | 0.206 |
 Basic knowledge on HIV and treatment | 238 (64.9) | 109 (45.8) | 129 (54.2) |  |
 Extensive knowledge on HIV and treatment | 129 (35.1) | 68 (52.7) | 61 (47.3) |  |
Qualify relationship with caregiver | 370 | 178 | 192 | 0.301 |
 More than medical | 193 (52.2) | 98 (50.8) | 95 (49.2) |  |
 Not only medical but not quite good | 48 (13.0) | 25 (52.1) | 23 (47.9) |  |
 Strictly medical | 129 (34.9) | 55 (42.6) | 74 (57.4) |  |